Medical Isotopes save lives.

Nuclear Medicine departments at hospitals and cancer treatment centres use radioisotopes for both diagnosis of disease (such as cancer & cardiovascular disease) as well as therapy for some forms of cancer.  Radioisotopes are an unstable form of an element that emits radiation to transform into a more stable form.  For therapy, the isotope is part of a drug that seeks diseased cells, typically cancers.  The radiation emitted by the isotope can then destroy the cells with considerable focus to limit other cell damage.

Copper 67 (Cu-67) is an emerging therapy medical isotope for new cancer treatments. Cu-67 is an ideal radiotherapy medical isotope similar to yttrium-90 (Y-90), iodine-131 (I-131) and lutetium-177 (Lu-177) medical isotopes that are already in use for immunology.  However, production of these other isotopes (Y-90, I-131 and Lu-177) relies on aging nuclear research reactors and processing facilities, resulting in uncertain availability and high replacement costs.

Through cutting-edge diagnostic technology, isotopes (Technetium -99m – Tc-99m) are used to identify internal ailments and allow medical professionals to quickly and accurately treat patients. Previously, the production of these medical isotopes occurred only at a small number of nuclear facilities, which created harmful waste and came with a long list of security and supply concerns.

Our goal at CIIC is the production of safe, pure medical isotopes produced in a direct and reliable manner. We are the first producer of reactor-free medical isotopes on a commercial scale, providing a solution to a worldwide shortage.

Our dependable product and supply chain allows physicians to help patients with the care they need. Through entrepreneurial innovation and advanced technology, our process is clean, safe, and renewable.

Our Team

We are a team of dedicated professionals committed to innovating the radiopharmaceutical industry by producing clean, pure medical isotopes without the use of outdated nuclear reactors.

Mark de Jong, Chief Technology Officer of Canadian Isotope Innovations.

Mark de Jong

Chief Technology Officer


Beryl Lepage, Chief Financial Officer of Canadian Isotope Innovations.

Beryl Lepage

Chief Financial Officer

Beryl is responsible for financial, administrative, and human resource management. Beryl oversees all aspects of capital and operational funding and expenditures including all contractual arrangements. … More...

Doug Ullrich, VP Engineering of Canadian Isotope Innovations.

Doug Ullrich

VP Engineering

Doug Ullrich leads the design and development of technology to safely produce and handle the radioactive isotopes. His unique technical background - knowledge of world-class quality management systems, nuclear regulatory affairs and nuclear global supply chain issues, are demonstrated in… More...

Vijay Gaja, Operations Manager of Canadian Isotope Innovations.

Vijay Gaja

Operations Manager

Dr. Vijay Gaja leads all operational aspects of CIIC product development and production. Utilizing his extensive knowledge of radiochemistry and various radionuclide production platforms, Vijay has developed and optimized the processing, separations and purification of radiopharmaceuticals… More...

Hao Zhang, Engineer, Operation & Control Systems of Canadian Isotope Innovations.

Hao Zhang

Engineer, Operation & Control Systems

Hao Zhang is a Professional Engineer responsible for the engineering design and implementation of critical control and safety systems. Hao manages the linear accelerator facility operation, as well as project management for the development of the novel accelerator technology and… More...

James dela Cruz, Engineering Physicist of Canadian Isotope Innovations.

James dela Cruz

Engineering Physicist

James dela Cruz provides key operational support for isotope production including the accelerator and instrumentation for processing, purification and quality control of the medical isotope products. James also leads the computational support for the production performance of the target… More...

Taylor Melnychuk, Radiopharmaceutical Technician of Canadian Isotope Innovations.

Taylor Melnychuk

Radiopharmaceutical Technician

Taylor joined the CIIC production team after graduating from the University of Saskatchewan with a Bachelor of Science in Physiology and Pharmacology. She is a key participant in the production cycle, particularly focused on quality control activities. She is involved in dissolution and… More...

Our Partners

Canadian Light Source

Canadian Light Source

The Canadian Light Source is a national research facility, one of the largest science projects in our country’s history, and the brightest light in Canada—millions of times brighter than even the sun—used by scientists from around the world in ground-breaking health, environmental,… More...